|
Clinicopathological features
|
N.
|
PTEN protein expression
|
P-value
|
|---|
|
0
|
1+
|
2+
|
3+
|
PR (%)
|
|---|
|
Total cases (cancerous)
|
125
|
41
|
34
|
37
|
13
|
67.2
| |
|
Age
| | | | | | |
0.943
|
|
< 50
|
18
|
6
|
4
|
6
|
2
|
66.7
| |
|
≥ 50
|
107
|
35
|
30
|
31
|
11
|
67.2
| |
|
Sex
| | | | | | |
0.251
|
|
Female
|
55
|
15
|
16
|
18
|
6
|
72.7
| |
|
Male
|
70
|
26
|
18
|
19
|
7
|
62.8
| |
|
Tumor size (cm)
| | | | | | |
0.007
|
|
≤ 5
|
79
|
19
|
23
|
27
|
10
|
76
| |
|
> 5
|
46
|
22
|
11
|
10
|
3
|
52.2
| |
|
TNM Stage
| | | | | | |
0.011
|
|
I & II
|
25
|
3
|
6
|
12
|
4
|
88
| |
|
III & IV
|
100
|
38
|
28
|
25
|
9
|
62
| |
|
Tumor Differentiation
| | | | | | |
0.534
|
|
High
|
65
|
19
|
17
|
18
|
11
|
70.8
| |
|
Moderate
|
49
|
17
|
14
|
16
|
2
|
65.3
| |
|
Low
|
11
|
5
|
3
|
3
|
0
|
54.5
| |
|
PTEN Promoter methylation
| | | | | | |
0.013
|
|
Methylated
|
39
|
18
|
15
|
4
|
2
|
53.8
| |
|
Unmethylated
|
86
|
23
|
19
|
33
|
11
|
73.2
| |
-
PR positive rate, TNM Tumor, Node Metastases staging system
